Characteristics | HD (n = 31) | PD (n = 29) | P | |
---|---|---|---|---|
Demographic data | ||||
Female (n) | 11 (35.50%) | 10 (34.50%) | 0.94 | |
Age at dialysis initiation (years) | 60.0 ± 11.7 | 54.6 ± 10.3 | 0.06 | |
Duration of follow up (months) | 40.0 (31.0, 49.1) | 54.0 (46.5, 61.6) | 0.02 | |
Kidney primary disease | ||||
Diabetic nephropathy (n) | 12 (38.70%) | 16 (55.20%) | 0.20 | |
Glomerulus nephritis (n) | 8 (25.80%) | 0 (0.00%) | <0.01 | |
Polycystic kidney (n) | 1 (3.20%) | 0 (0.00%) | 0.33 | |
Obstructive nephropathy (n) | 2 (6.50%) | 4 (13.80%) | 0.34 | |
Other or unknown (n) | 8 (25.80%) | 9 (31.00%) | 0.65 | |
Comorbidities | ||||
Charlson Comorbidities Index (CCI) | 6.4 ± 1.8 | 6.1 ± 1.3 | 0.54 | |
Cardiovascular disease (n) | 13 (41.90%) | 10 (34.50%) | 0.55 | |
Congestive heart failure (n) | 2 (6.50%) | 3 (10.30%) | 0.59 | |
Cerebrovascular disease (n) | 9 (29.00%) | 5 (17.20%) | 0.28 | |
Chronic pulmonary disease (n) | 6 (19.40%) | 9 (31.0%) | 0.30 | |
Laboratory tests | ||||
Serum Urea (mmol/L) | 22.9 ± 6.6 | 25.7 ± 8.9 | 0.17 | |
Serum creatinine (umol/L) | 814 (769, 859) | 970 (839, 1101) | 0.02 | |
Triglyceride (mmol/L) | 2.4 (1.9, 2.9) | 2.3 (1.7, 2.9) | 0.80 | |
Cholesterol (mmol/L) | 5.0 ± 1.1 | 5.6 ± 0.9 | 0.04 | |
Plasma albumin (g/L) | 35.5 ± 4.7 | 34.7 ± 4.9 | 0.50 | |
Hemoglobin (g/L) | 95.4 ± 18.3 | 97.5 ± 20.5 | 0.67 |